Finance

Beta
Lists
4888:TYO
Stella Pharma Corp
¥349.00
+5.12%
(+17.00) 1D
Jun 3, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4888...
Open
¥332
High
¥349
Low
¥330
Mkt. cap
12.23B
Avg. vol.
1.08M
Volume
307.70K
52-wk high
¥995
52-wk low
¥200
EPS
-¥23
No. of employees
43
Open
¥332
High
¥349
Low
¥330
Mkt. cap
12.23B
Avg. vol.
1.08M
Volume
307.70K
52-wk high
¥995
52-wk low
¥200
EPS
-¥23
No. of employees
43
News stories
From sources across the web
About Stella Pharma Corp
CEOTomoyuki Asano
Employees43
FoundedJun 1, 2007
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
92.00M
108.00M
61.00M
62.00M
Cost of goods sold
13.00M
22.00M
1.00M
8.00M
Cost of revenue
13.00M
22.00M
1.00M
8.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
231.00M
233.00M
274.00M
290.00M
Operating expense
231.00M
233.00M
274.00M
290.00M
Total operating expenses
244.00M
255.00M
275.00M
298.00M
Operating income
-152.00M
-147.00M
-214.00M
-236.00M
Other non operating income
-3.00M
-2.00M
12.00M
-29.00M
EBT including unusual items
-156.00M
-150.00M
-204.00M
-268.00M
EBT excluding unusual items
-156.00M
-150.00M
-204.00M
-268.00M
Income tax expense
-
1.00M
1.00M
-
Effective tax rate
-
-0.67%
-0.49%
-
Other operating expenses
-
-
-
-
Net income
-156.00M
-151.00M
-205.00M
-268.00M
Net profit margin
-169.57%
-139.81%
-336.07%
-432.26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.00M
-1.00M
-2.00M
-3.00M
Net interest expenses
-1.00M
-1.00M
-2.00M
-3.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-143.50M
-140.00M
-205.50M
-229.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more